Streetbeat News

Products Services

APVO

ATORX

Alligator Bioscience (ATORX) and Aptevo Therapeutics (NASDAQ:APVO) announced positive interim data from their Phase 1 trial of ALG.APV-527 for solid tumors expressing 5T4. The trial showed favorable drug exposure, confirmed biological activity, and early signs of clinical activity in heavily pretreated patients. The trial is over 50% enrolled, with dose escalation ongoing. Both companies highlighted the potential of ALG.APV-527 in treating multiple tumor types and expressed optimism for future development.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 1:59 pm

GBTC

IBIT

Bitcoin spot ETFs experienced significant net inflows of $332 million on March 6, outperforming gold ETFs. The Grayscale Bitcoin Trust (GBTC) saw a net outflow of $276 million, while BlackRock's iShares Bitcoin Trust (IBIT) led with $281 million in net inflows, totaling $9.45 billion historically. The approval of the first Bitcoin spot ETF in January 2024 and its comparison to the first gold ETF's impact on gold prices highlight the growing investor interest in cryptocurrency as an asset class.

Portfolio Pulse from Murtuza Merchant

March 07, 2024 | 1:55 pm

BDC

Belden Inc. has introduced a new Single Pair Ethernet Lite Managed Switch, expanding its portfolio in networking solutions. This product is designed to enhance industrial connectivity by providing a more efficient and reliable networking option for various applications.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 1:53 pm

ADSE

NXT 50five, a joint venture between 50five and NXT Mobility, part of the GP Groot initiative, has won a tender from the Metropolitan Region of Amsterdam (MRA-Electric) to install and operate public rapid charging stations using ADS-TEC Energy's technology. The project involves up to 600 locations, addressing network congestion issues with battery-buffered rapid charging solutions. Installation for the first nine of up to 200 stations is underway.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 1:51 pm

DXCM

PLTR

SLG

SL Green Realty, Palantir Technologies, and DexCom were featured on CNBC's 'Final Trades'. SL Green Realty reported weaker-than-expected Q4 results. Palantir was awarded a $178.4 million Army contract for the TITAN ground station system. DexCom's Stelo Glucose Biosensor System received FDA approval as the first OTC continuous glucose monitor. Shares of SLG, PLTR, and DXCM saw gains in their recent trading sessions.

Portfolio Pulse from Avi Kapoor

March 07, 2024 | 1:51 pm

AIM

AIM ImmunoTech has introduced a new platform called CEO Corner, aimed at offering additional insights into press releases, corporate developments, and progress in their pipeline. This platform will also allow stakeholders to ask questions and suggest topics for future videos, enhancing communication between the company and its audience.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 1:46 pm

BTDR

Bitdeer Technologies Group (NASDAQ:BTDR) reported a 64% increase in Bitcoin mined in February 2024 compared to the previous year, totaling 287 Bitcoins. The company introduced its first Bitcoin mining chip, the 4nm SEAL01, designed for the new SEALMINER A1 machines, marking its entry into the ASIC production space. Bitdeer also announced progress on its infrastructure projects, including the commencement of land preparation for a 221MW datacenter in Ohio and the ongoing construction of a 175MW immersion cooling datacenter in Norway, both expected to be operational by mid-2025.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 1:44 pm

BLIN

HawkSearch, a Bridgeline product, is set to launch its 'Zeus' update on March 15, 2024, introducing AI-powered Concept and Visual Search to enhance revenue generation for its customers. The update leverages AI models, vector databases, and large language models for processing queries.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 1:43 pm

TOMZ

TOMI Environmental Solutions has expanded its SteraMist iHP corporate service contracts, adding new partners such as The University of Texas and Rising Pharmaceuticals. Financial terms of the deals were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 1:42 pm

CLBT

Cellebrite DI Ltd. (NASDAQ:CLBT) has initiated the FedRAMP authorization process for its SaaS offerings to enhance cloud security for federal customers. This move aims to support faster procurement, eliminate redundant assessments, and ensure high security standards. Cellebrite has partnered with cybersecurity firm Coalfire for this process, expected to complete within 12 months. Coalfire is recognized for its expertise in achieving FedRAMP authorization efficiently. Cellebrite's SaaS solutions, like Guardian, aim to improve operational efficiencies and case management in digital investigations.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 1:39 pm